{"schema_version":"secwatch.filing_event.v1","accession":"0001517022-25-000010","form_type":"8-K","ticker":"AKBA","cik":"0001517022","company_name":"Akebia Therapeutics, Inc.","filed_at":"2025-02-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.859626+00:00","generated_at":"2026-05-27T00:54:04.289038+00:00","sec_items":["1.01","2.03","3.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Akebia draws $9.3M net from extended loan tranche; issues warrant for 1.15M shares","bullets":["Extended Tranche C expiry from Dec 31, 2024 to Feb 3, 2025; interest accrues from Dec 31, 2024.","Drew $10M Tranche C on Feb 3, 2025; net proceeds of $9.3M after debt issuance costs and interest.","Issued warrant to Kreos Capital affiliate for 1,153,846 shares at $1.30 exercise, 8-year term.","Warrant not registered; relies on Section 4(a)(2) and Rule 506(b) exemption.","Loan facility total $55M; prior tranches of $37M and $8M already drawn."],"urls":{"canonical":"https://secwatch.observer/filing/0001517022-25-000010","json":"https://secwatch.observer/filing/0001517022-25-000010.json","markdown":"https://secwatch.observer/filing/0001517022-25-000010.md","text":"https://secwatch.observer/filing/0001517022-25-000010.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000010/0001517022-25-000010-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517022/000151702225000010/akba-20250203.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T00:54:04.289038+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}